Sarah Friis Christensen

7PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersHaematological tumoursNutritional epidemiologyMedical mycologyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2025
Statins enhance the efficacy of pegylated interferon-alfa2 in Philadelphia-negative chronic myeloproliferative neoplasms.

Isabella Diana Davidsen, Morten Kranker Larsen, Lea Löffler

|Jan 16, 2024
JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms.

Christina Schjellerup Eickhardt-Dalbøge, Henrik V Nielsen, Kurt Fuursted

|Sep 11, 2023
Pronounced gut microbiota signatures in patients with JAK2V617F-positive essential thrombocythemia.

Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Henrik V Nielsen

|Sep 01, 2023
Labor market affiliation of patients with myeloproliferative neoplasms: a population-based matched cohort study.

Lise Skovgaard Svingel, Sarah Friis Christensen, Anders Kjærsgaard

|Oct 19, 2022
The gut microbiota in patients with polycythemia vera is distinct from that of healthy controls and varies by treatment.

Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Lee O'Brien Andersen

|Jul 28, 2022
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study.

Sarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjaersgaard

Pageof 2

Frequent Collaborators

5 joint publications

Hans Carl Hasselbalch

4 joint publications

Vibe Skov

4 joint publications

Trine Alma Knudsen

4 joint publications

Christina Schjellerup Eickhardt-Dalbøge